Monday broker round-up
22nd Aug 2016 09:09
(ShareCast News) - William Hill: Barclays reiterates overweight with a target price of 340p. Anglo American: JP Morgan maintains overweight with a 1100p target. Rio Tinto: Macquarie reiterates outperform with a 2900p target. Admiral Group: Berenberg reiterates underweight with a 1746p target. Eas
Read moreIndivior hails slow-release heroin treatment trial data
17th Aug 2016 07:54
(ShareCast News) - Indivior's new heroin addiction treatment has proved successful in late-stage clinical trials, the company announced on Wednesday, meaning it could be approved for sale in the US by the end of next year. RBP-6000, a monthly slow-release 'depot' formulation of Buprenorphine that is
Read moreMonday broker round-up
1st Aug 2016 09:49
(ShareCast News) - Thomas Cook: Berenberg reiterates hol d with a target price of 60p. Diageo: JP Morgan maintains overweight with a 2400p target. Indivior: Jefferies reiterates buy with a 330p target. Anglo American: HSBC stays at hold with a 930p target. Just Eat: UBS keeps at sell with a targ
Read moreIndivior lifts guidance as H1 sales rise
29th Jul 2016 07:58
(ShareCast News) - FTSE 250 specialty pharmaceuticals firm Indivior lifted its full-year guidance on Friday as it reported a rise in first-half net sales. For the half to 30 June, net revenue rose to $531m from $517m in the same period a year ago. However, operating profit declined to $198m from $23
Read moreFTSE 250 movers: house builders in focus as mid caps sour
4th Jul 2016 18:25
(ShareCast News) - FTSE 250 stocks ended on a sour note with residential property-linked stocks figuring prominently among the fallers as UK construction data disappointed. Clarkson led to the downside as it warned full-year 2016 profits would be "materially lower" on the year due to lower freight r
Read moreFTSE 250 movers: Go Ahead hits buffers; N Brown update in fashion
16th Jun 2016 13:04
(ShareCast News) - Go-Ahead shares were going nowhere on Thursday after commuters on Britain's largest railway franchise were lumped with the promise of more misery this week, as conductors on the Southern arm of Govia Thameslink Railway announced a strike, set down for next Tuesday. The railway fra
Read moreMonday broker round-up
6th Jun 2016 12:55
(ShareCast News) - Wolseley: JP Morgan reiterates neutral with a target price of 4100p. Cairn Energy: RBC reiterates sector perform with a 250p target. Shire: Jefferies reiterates buy with a target price of 6050p and Exane BNP Paribas stays at outperform. Cobham: JP Morgan keeps at neutral with a
Read moreIndivior shares slump as it posts drop in Q1 profit
3rd May 2016 12:09
(ShareCast News) - Shares in Indivior tumbled after the FTSE 250 speciality pharmaceuticals firm reported a drop in first-quarter profit. Pre-tax profit fell to $86m (£58.6m) from $102m in the same period a year ago, while net income slid to $50m from $77m. Operating profit slipped 12% to $101m whi
Read moreIndivior hit by Phase I trial failure and manufacturing issue
28th Apr 2016 14:54
(ShareCast News) - Indivior has abandoned further development of a pill to treat heroin addiction and said the potential approval of a monthly treatment for schizophrenia was likely to be delayed after a external manufacturing issue. The FTSE 250 drug developer said it was giving up on the devel
Read moreFTSE 250 movers: Takeover talks send Entertainment One higher
14th Apr 2016 14:38
(ShareCast News) - The FTSE 250 was trading down on Thursday afternoon, after a unanimous Bank of England decision to keep interest rates steady for the 85th month in a row. Film and television distributor Entertainment One was on the up, after it was revealed that broadcaster ITV held takeover talk
Read moreFTSE 250 movers: Evraz rises with iron, appetite for Just Eat wanes
7th Mar 2016 14:40
(ShareCast News) - The FTSE 250 was down during afternoon trading on Monday, after an earlier report showed Eurozone investor confidence was expected to fall in March ahead of the European Central Bank's policy meeting later in the week. Indivior was one of the leading risers after Deutsche Bank rei
Read moreIndivior lifts profits but promises last dividend for foreseeable future
18th Feb 2016 08:15
(ShareCast News) - Profits and sales from Indivior both fell by less than expected as the speciality pharmaceuticals business completed an encouraging first year as a public company since being demerged from Reckitt Benckiser. Net revenue fell 9% to $1.01bn, at the upper range of its increased guida
Read moreIndivior agrees to repurchase $75m debts
7th Dec 2015 08:16
(ShareCast News) - Pharmaceutical group Indivior has agreed a deal to buy back $75m ($49.8m) worth of syndicated debts. The FTSE 250 group said it will retire the debt during the course of the week , adding it expects debt for the 2015 financial year to be between $635m and $645m, with cash resource
Read moreIndivior raises 2015 guidance but quarterly income declines
3rd Nov 2015 12:31
(ShareCast News) - Specialty pharmaceuticals company Indivior posted a 9% drop in third-quarter revenue but lifted its revenue and income guidance for the full year. For the three months to the end of September, net revenue came in at $766m (£498m) compared with $844m (£548.6m) in the same period la
Read moreFrance's unemployment improves by most since 2007
26th Oct 2015 16:40
(ShareCast News) - France's unemployment data showed one of its largest declines since before the financial crisis began. The number of jobless people slipped by 23,800 in September to 3.55m, data from the Labour Ministry showed, which represented a 0.7% month-on-month decline but a 3.1% rise on
Read more